BREAKING:

The Pharmacological Pivot: How GLP-1 Agonists and Biometric Surveillance are Rewriting the Economics of Human Performance|The Telemetry of the Mind: How Biometric Surveillance is Rewriting the Economics of Elite Performance|The $31.7 Billion Illusion: How AI and Monopoly Are Reshaping the Music Economy

Truth • Integrity • Excellence

#AI Clinical Trials

Explore our comprehensive coverage of ai clinical trials, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

3Articles

3Authors

111Total Views

The Architecture of Human Longevity: How Multiplex Agonists and In Vivo Editing are Rewiring Clinical Economics

Featured

By Katherine Anne WhitfieldOct 27, 2026

The Architecture of Human Longevity: How Multiplex Agonists and In Vivo Editing are Rewiring Clinical Economics

The convergence of multiplex metabolic agonists, in vivo CRISPR editing, and AI-driven clinical modeling is commodifying human longevity, transforming...

Read Full Story →

Recent Articles

The Biometric Ledger: How Decentralized Telemetry and AI Pathogen Treaties Are Liquidating the Legacy Public Health Model

Public Health

Oct 22, 20265 min

The Biometric Ledger: How Decentralized Telemetry and AI Pathogen Treaties Are Liquidating the Legacy Public Health Model

The simultaneous FDA approval of consumer metabolic wearables, the WHO's Pathogen X treaty, and a ma...

Benjamin Thomas Hartley💬 0

The Biological Margin Call: How In Vivo CRISPR and Algorithmic Trials are Rewiring Medical Research Economics

Fashion

Aug 11, 20265 min

The Biological Margin Call: How In Vivo CRISPR and Algorithmic Trials are Rewiring Medical Research Economics

The 2026 convergence of the first Phase 3 in vivo CRISPR trial, FDA AI-enabled clinical trial optimi...

Olivia Grace Chen💬 0